Stockreport

AgeX Therapeutics Announces Reduction in Projected Cash Expenditures

AgeX Therapeutics, Inc.  (AGE) 
PDF ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regenerat [Read more]